HERBALIFE LTD.
For the period ended Sep 30, 2026. Filed Nov 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 2, 2026
HLF$15.59-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||
|---|---|---|
| September 30,2026 | September 30,2025 | |
| (in millions) | ||
| Cash flows from operating activities: | ||
| Net income | $91.8 | $142.7 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 91.3 | 91.9 |
| Share-based compensation expenses | 29.4 | 33.2 |
| Non-cash interest expense | 9.2 | 12.3 |
| Deferred income taxes | 4.8 | 5.3 |
| Inventory write-downs | 18.1 | 21.4 |
| Foreign exchange transaction loss | 1.4 | 1.6 |
| Loss on extinguishment of debt | 94.6 | — |
| Other | 2.3 | (1.2) |
| Changes in operating assets and liabilities: | ||
| Receivables | (24.2) | (25.6) |
| Inventories | (22.2) | (29.8) |
| Prepaid expenses and other current assets | (3.2) | 8.9 |
| Accounts payable | (5.1) | 12.4 |
| Member compensation liabilities | 3.8 | (5.0) |
| Other current liabilities | 31.1 | (13.1) |
| Other | (25.1) | (20.0) |
| Net cash provided by operating activities | 298.0 | 235.0 |
| Cash flows from investing activities: | ||
| Purchases of property, plant, and equipment | (40.7) | (61.9) |
| Acquisitions of business and assets | (10.0) | (25.5) |
| Other | (0.9) | (2.6) |
| Net cash used in investing activities | (51.6) | (90.0) |
| Cash flows from financing activities: | ||
| Borrowings from senior secured credit facility and other debt | 785.5 | 552.3 |
| Principal payments on senior secured credit facility and other debt | (884.1) | (543.9) |
| Proceeds from senior secured notes due 2033 | 800.0 | — |
| Repayment of senior secured notes due 2029 | (849.0) | — |
| Repayment of senior notes due 2025 | — | (262.3) |
| Debt issuance costs | (21.9) | (0.1) |
| Share repurchases | (10.2) | (8.1) |
| Other | 9.0 | (0.7) |
| Net cash used in financing activities | (170.7) | (262.8) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (18.9) | 7.7 |
| Net change in cash, cash equivalents, and restricted cash | 56.8 | (110.1) |
| Cash, cash equivalents, and restricted cash, beginning of period | 375.3 | 438.1 |
| Cash, cash equivalents, and restricted cash, end of period | $432.1 | $328.0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.